(PharmaNewsWire.Com, May 29, 2017 ) As per the syndicated report published by Market Data Forecast Europe Autoimmune Monoclonal Antibodies Market which is estimated to be USD 5718.7 million in 2016 is poised to reach USD 8302.0 million by 2021, at a CAGR of 7.74% from 2016 to 2021.Increasing research and development, increase in cases of autoimmune disorders, and increasing involvement of public and private organization to boost development of new therapies is driving the market growth. Also adoption of advanced therapeutics is contributing to the growth of the market. However, high cost of treatment and side effects related to antibodies usage is causing hindrance to the market growth.
Antibodies are defined as proteins that are produced by plasma to fight some specific antigen. The process used for treatment of various kinds of chronic diseases is called monoclonal antibodies. These are applied in treatment of diseases like cancer, rheumatoid arthritis, psoriasis, Crohns diseases and others. Monoclonal antibodies offer less toxic and more efficient therapeutic alternatives to treat autoimmune diseases. In recent years the emergences of monoclonal antibodies have been seen as being used to treat number of diseases that are related to immune response. Many new products are being launched during forecast period.
Technological advancement and availability of next-generation antibody products are also boosting the growth of the global antibodies market.
Europe Autoimmune Monoclonal Antibodies Market is segmented based on mode of drug type and application as mentioned below for attaining a more granular perspective of the market. In the report each sub segment is provided with Market Size Estimations and Y-o-Y Forecasts.
Geographically, the market is segmented into U.K., Italy, France, Germany and Spain.The report justifies this by offering country wise data for the EU5 countries while taking some other predominant economies into consideration as well. U.K.
The key players in Autoimmune Monoclonal Antibodies market include, GlaxoSmithKline plc. (U.K.), AstraZeneca plc. (U.K.), F. Hoffmann-La Roche Ltd. (Switzerland), Bristol-Myers Squibb (U.S.), Johnson & Johnson (U.S.), Innovent Biologics, Inc. (China), Takeda Pharmaceutical Company Ltd. (Japan), Amgen Inc. (U.S.), Biogen Inc.(U.S.), and UCB Company (Belgium). Major big players are focused on co-development and co-marketing of products in order to gain an upper hand in market presence. Moreover, collaborations and partnerships also enable these companies to increase visibility of their products in markets across the concerned regions.
The Autoimmune Monoclonal Antibodies Market study offers the following deliverables:
Regional and country-level analysis that provides an innate perspective of European region and the aforementioned countries
Meticulously identifying the key areas of market growth by providing market size forecasts and y-o-y estimations at a Segment-level analysis
Explanations of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
Study of macro and micro environmental factors that affect the European market presented in the form of PESTLE and Porters Five Forces Analyses
Company overview, product portfolios, key financial information (subjected to availability), SWOT analysis and analyst overview of the key market players operating in the region
Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
Expertly devised Market Outlook - Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
About Market Data Forecast: The publisher of this report Market Data Forecast is well known for the services they render in the area of market research and business intelligence. With rich experience in research across various business domains, they cater to the needs of both individual and corporate clients. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering Europe among other regions of the global market as well, that too with competitive pricing options. For more info kindly visit, www.marketdataforecast.com
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
